Price T Rowe Associates Inc. MD Acquires 15,156 Shares of Sotera Health (NASDAQ:SHC)

Price T Rowe Associates Inc. MD boosted its holdings in shares of Sotera Health (NASDAQ:SHC) by 20.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 89,668 shares of the company’s stock after purchasing an additional 15,156 shares during the quarter. Price T Rowe Associates Inc. MD’s holdings in Sotera Health were worth $1,227,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Khrom Capital Management LLC purchased a new position in shares of Sotera Health in the fourth quarter worth $4,998,000. Tower Research Capital LLC TRC lifted its stake in Sotera Health by 37.8% in the 4th quarter. Tower Research Capital LLC TRC now owns 5,975 shares of the company’s stock worth $82,000 after purchasing an additional 1,640 shares in the last quarter. Voss Capital LP boosted its holdings in shares of Sotera Health by 42.9% during the 4th quarter. Voss Capital LP now owns 500,000 shares of the company’s stock valued at $6,840,000 after purchasing an additional 150,000 shares during the last quarter. MetLife Investment Management LLC grew its position in shares of Sotera Health by 9.1% during the fourth quarter. MetLife Investment Management LLC now owns 86,177 shares of the company’s stock valued at $1,179,000 after purchasing an additional 7,174 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its holdings in shares of Sotera Health by 27.3% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,143,955 shares of the company’s stock worth $43,004,000 after purchasing an additional 673,979 shares during the last quarter. 91.03% of the stock is owned by hedge funds and other institutional investors.

Sotera Health Stock Performance

NASDAQ SHC opened at $13.13 on Friday. The business’s 50 day moving average price is $11.45 and its 200-day moving average price is $12.95. Sotera Health has a fifty-two week low of $9.53 and a fifty-two week high of $17.08. The company has a market cap of $3.73 billion, a P/E ratio of 52.52 and a beta of 1.88. The company has a debt-to-equity ratio of 4.91, a quick ratio of 2.61 and a current ratio of 2.88.

Sotera Health (NASDAQ:SHC) last posted its quarterly earnings data on Thursday, May 1st. The company reported $0.14 earnings per share for the quarter, beating analysts’ consensus estimates of $0.12 by $0.02. The business had revenue of $254.52 million for the quarter, compared to analysts’ expectations of $245.56 million. Sotera Health had a net margin of 6.31% and a return on equity of 42.27%. The business’s revenue was up 2.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.13 earnings per share. Sell-side analysts predict that Sotera Health will post 0.61 earnings per share for the current year.

Analyst Upgrades and Downgrades

SHC has been the subject of a number of research reports. Piper Sandler dropped their price target on Sotera Health from $15.00 to $13.00 and set a “neutral” rating for the company in a research note on Wednesday, April 23rd. The Goldman Sachs Group raised shares of Sotera Health from a “neutral” rating to a “buy” rating and raised their target price for the company from $14.00 to $17.00 in a report on Monday, May 5th. Finally, Barclays decreased their price target on shares of Sotera Health from $16.00 to $12.00 and set an “overweight” rating on the stock in a research note on Thursday, April 10th. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $15.80.

Sotera Health Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.